Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy.

Pharmaco-resistance developed in approximately 20% of patients with PSE and was associated with younger age at stroke onset, stroke type and severity, status epilepticus occurrence, and seizure types.